返回
Virax Biolabs Group Ltd（VRAX）價格
VRAX 股價走勢圖
VRAX 收益
Virax Biolabs Group Ltd
$0.3
-2.54%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$0.29
-5.22%
$-0.01
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$0.314
開盤價
$0.3129
當日範圍
$0.29 - $0.3299
52週區間
$0.29 - $2.33
交易量
299.1K
平均成交量
5.1M
每股盈餘 (TTM)
-1.25
股息收益率
--
市值
$1.8M
什麼是 VRAX？
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The firm is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The firm is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
